Compounds > 8-azidoadenosine-3',5'-monophosphate
Page last updated: 2024-09-03

8-azidoadenosine-3',5'-monophosphate and anthralin

8-azidoadenosine-3',5'-monophosphate has been researched along with anthralin in 1 studies

Compound Research Comparison

Studies
(8-azidoadenosine-3',5'-monophosphate)		Trials
(8-azidoadenosine-3',5'-monophosphate)		Recent Studies (post-2010)
(8-azidoadenosine-3',5'-monophosphate)		Studies
(anthralin)		Trials
(anthralin)		Recent Studies (post-2010) (anthralin)
11911982151102

Protein Interaction Comparison

ProteinTaxonomy8-azidoadenosine-3',5'-monophosphate (IC50)anthralin (IC50)
microphthalmia-associated transcription factor isoform 9Homo sapiens (human)0.2317
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)7
NAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)0.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benes, P; Benz, RE; Färber, L; Langendorf, Y; Schopf, RE1

Trials

1 trial(s) available for 8-azidoadenosine-3',5'-monophosphate and anthralin

ArticleYear
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
    The Journal of investigative dermatology, 2002, Volume: 119, Issue:1

    Topics: Administration, Topical; Adolescent; Adult; Affinity Labels; Aged; Anthralin; Anti-Inflammatory Agents; Azides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Dermatologic Agents; Erythrocyte Membrane; Etretinate; Female; Humans; Keratolytic Agents; Male; Middle Aged; Protein Binding; Psoriasis; Retinoids; Severity of Illness Index

2002